Parkinson Risk Assessment Out of Blood Samples
A new method for diagnosis and prognosis of Parkinson’s disease
Invention: Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease affecting about 2% of the population over 65. The most prominent neuro¬patho¬logical characteristics of PD are progressive cell death within the nigrostriatal system and the appearance of cytoplasmatic aggregates of alpha-synuclein (SNCA), so-called Lewy bodies. The disease is typically diagnosed in an advanced stage when 70% of the dopaminergic neurons are lost. Especially in the light of new disease-modifying treat-ments, there is a great need for the early detection of PD. Scientists of the University of Bonn have found that the methylation pattern of the SNCA-gene is indicative for patients having developed PD. Surprisingly, it could be shown that said methylation status can be assessed based on DNA from peripheral blood cells.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
A universal framework for spatial biology
SpatialData is a freely accessible tool to unify and integrate data from different omics technologies accounting for spatial information, which can provide holistic insights into health and disease. Biological processes…
How complex biological processes arise
A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at…
Airborne single-photon lidar system achieves high-resolution 3D imaging
Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…
